Anchor Investment Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.61K | Hold |
312
| – | – | ﹤0.01% | 842 |
|
|
2025
Q1 | $6.49K | Hold |
312
| – | – | ﹤0.01% | 855 |
|
|
2024
Q4 | $7.36K | Sell |
312
-20
| -6% | -$472 | ﹤0.01% | 840 |
|
|
2024
Q3 | $8.51K | Buy |
332
+28
| +9% | +$718 | ﹤0.01% | 808 |
|
|
2024
Q2 | $7.15K | Buy |
304
+37
| +14% | +$870 | ﹤0.01% | 801 |
|
|
2024
Q1 | $7.69K | Buy |
267
+17
| +7% | +$490 | ﹤0.01% | 822 |
|
|
2023
Q4 | $8.22K | Buy |
250
+50
| +25% | +$1.64K | ﹤0.01% | 775 |
|
|
2023
Q3 | $5.58K | Hold |
200
| – | – | ﹤0.01% | 820 |
|
|
2023
Q2 | $6.83K | Buy |
200
+25
| +14% | +$854 | ﹤0.01% | 793 |
|
|
2023
Q1 | $5.28K | Buy |
175
+42
| +32% | +$1.27K | ﹤0.01% | 828 |
|
|
2022
Q4 | $3.77K | Hold |
133
| – | – | ﹤0.01% | 827 |
|
|
2022
Q3 | $4.39K | Hold |
133
| – | – | ﹤0.01% | 814 |
|
|
2022
Q2 | $4.2K | Buy |
133
+25
| +23% | +$790 | ﹤0.01% | 833 |
|
|
2022
Q1 | $4.98K | Sell |
108
-384
| -78% | -$17.7K | ﹤0.01% | 845 |
|
|
2021
Q4 | $30.1K | Buy |
+492
| New | +$30.1K | ﹤0.01% | 633 |
|